Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 1,416,224 | 1,299,704 | 1,163,980 | 1,112,179 | 928,517 |
Marketable Securities | 279,631 | 281,320 | 274,343 | 263,134 | 269,865 |
Receivables | 302,680 | 244,081 | 307,598 | 247,736 | 316,310 |
Inventories | 6,527 | 7,129 | 6,967 | 5,993 | 5,869 |
TOTAL | $2,058,625 | $1,904,500 | $1,832,254 | $1,700,359 | $1,598,084 |
Non-Current Assets | |||||
PPE Net | 339,122 | 338,331 | 319,751 | 300,767 | 267,586 |
Investments And Advances | 115,563 | 120,188 | 99,199 | 121,381 | 131,330 |
Intangibles | 204,596 | 209,980 | 215,364 | 220,748 | 226,132 |
Other Non-Current Assets | 229,727 | 181,162 | 179,194 | 176,692 | 174,025 |
TOTAL | $889,008 | $849,661 | $813,508 | $819,588 | $799,073 |
Total Assets | $2,947,633 | $2,754,161 | $2,645,762 | $2,519,947 | $2,397,157 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | N/A | N/A | 7,648 | 7,554 |
Accounts payable and accrued liabilities | 66,214 | 70,452 | 103,856 | 95,578 | 75,592 |
Accrued Expenses | 300,100 | 294,063 | 321,421 | 319,263 | 285,093 |
TOTAL | $367,105 | $364,515 | $425,277 | $422,489 | $368,239 |
Non-Current Liabilities | |||||
Other Non-Current Liabilities | 301,694 | 304,079 | 294,518 | 294,559 | 295,995 |
TOTAL | $333,337 | $304,079 | $294,518 | $294,559 | $295,995 |
Total Liabilities | $700,442 | $668,594 | $719,795 | $717,048 | $664,234 |
Shareholders' Equity | |||||
Shares Outstanding, K | 215,067 | 214,439 | 214,048 | 212,808 | 212,578 |
Common Shares | 215 | 214 | 213 | 213 | 212 |
Retained earnings | -1,670,034 | -1,775,352 | -1,877,759 | -1,946,822 | -1,975,998 |
Other shareholders' equity | -8,965 | -9,247 | -10,165 | -9,522 | -9,809 |
TOTAL | $2,247,191 | $2,085,567 | $1,925,967 | $1,802,899 | $1,732,923 |
Total Liabilities And Equity | $2,947,633 | $2,754,161 | $2,645,762 | $2,519,947 | $2,397,157 |